Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Leukemia & Lymphoma
|
February 10, 2010
OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia
Anjali S Advani, Kathleen Lim, Sarah Gibson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2004
Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses
Christine L O'Keefe, Magdalena Plasilova, Marcin Wlodarski, et al.
Leukemia Research
|
October 12, 2007
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML
Anjali S Advani, Cristina Rodriguez, Tao Jin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 14, 2002
Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders
Michele Paessler, Plamen Kossev, Donald Tsai, et al.
European Journal of Haematology
|
June 26, 2012
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia
Anna Brady, Sarah Gibson, Lisa Rybicki, et al.
Mayo Clinic Proceedings
|
July 14, 2006
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma
Mohamad A Hussein, Rachid Baz, Gordan Srkalovic, et al.
Cancer
|
August 8, 2013
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701
Barbara W Grant, Sin-Ho Jung, Jeffrey L Johnson, et al.
British Journal of Haematology
|
March 8, 2011
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Anjali S Advani, Sarah Gibson, Elizabeth Douglas, et al.
British Journal of Haematology
|
February 7, 2019
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)
Cara A Rosenbaum, Sin-Ho Jung, Brandelyn Pitcher, et al.
Journal of the National Cancer Institute
|
July 7, 2016
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
Yuhuan Zheng, Qiang Wang, Tianshu Li, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Leukemia & Lymphoma
|
February 10, 2010
OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia
Anjali S Advani, Kathleen Lim, Sarah Gibson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 22, 2004
Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses
Christine L O'Keefe, Magdalena Plasilova, Marcin Wlodarski, et al.
Leukemia Research
|
October 12, 2007
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML
Anjali S Advani, Cristina Rodriguez, Tao Jin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 14, 2002
Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders
Michele Paessler, Plamen Kossev, Donald Tsai, et al.
European Journal of Haematology
|
June 26, 2012
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia
Anna Brady, Sarah Gibson, Lisa Rybicki, et al.
Mayo Clinic Proceedings
|
July 14, 2006
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma
Mohamad A Hussein, Rachid Baz, Gordan Srkalovic, et al.
Cancer
|
August 8, 2013
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701
Barbara W Grant, Sin-Ho Jung, Jeffrey L Johnson, et al.
British Journal of Haematology
|
March 8, 2011
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
Anjali S Advani, Sarah Gibson, Elizabeth Douglas, et al.
British Journal of Haematology
|
February 7, 2019
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)
Cara A Rosenbaum, Sin-Ho Jung, Brandelyn Pitcher, et al.
Journal of the National Cancer Institute
|
July 7, 2016
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response
Yuhuan Zheng, Qiang Wang, Tianshu Li, et al.
Page
of 4